Maggie C.U. Cheang

2004–2024 年に発表

76
論文数
32,482
被引用数
59
h 指数
76
i10 指数

被引用数

Maggie C.U. Cheang の年別被引用数1990 年: 被引用 1 件1994 年: 被引用 2 件1997 年: 被引用 1 件1998 年: 被引用 1 件2004 年: 被引用 2 件2005 年: 被引用 44 件2006 年: 被引用 87 件2007 年: 被引用 144 件2008 年: 被引用 232 件2009 年: 被引用 248 件2010 年: 被引用 422 件2011 年: 被引用 432 件2012 年: 被引用 377 件2013 年: 被引用 424 件2014 年: 被引用 405 件2015 年: 被引用 419 件2016 年: 被引用 426 件2017 年: 被引用 391 件2018 年: 被引用 388 件2019 年: 被引用 1,133 件2020 年: 被引用 1,154 件2021 年: 被引用 1,048 件2022 年: 被引用 745 件2023 年: 被引用 548 件2024 年: 被引用 778 件2025 年: 被引用 377 件2026 年: 被引用 24 件1991〜1993 年は被引用が無いため表示していません1995〜1996 年は被引用が無いため表示していません1999〜2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,540 件、この内訳の 26.7%中国: 引用元論文 1,319 件、この内訳の 9.9%イギリス: 引用元論文 893 件、この内訳の 6.7%イタリア: 引用元論文 651 件、この内訳の 4.9%カナダ: 引用元論文 579 件、この内訳の 4.4%ドイツ: 引用元論文 525 件、この内訳の 4%スペイン: 引用元論文 465 件、この内訳の 3.5%フランス: 引用元論文 445 件、この内訳の 3.3%オーストラリア: 引用元論文 396 件、この内訳の 3%日本: 引用元論文 295 件、この内訳の 2.2%オランダ: 引用元論文 286 件、この内訳の 2.2%韓国: 引用元論文 284 件、この内訳の 2.1%
0%26.7%その他 27.1%

分野

  • Biochemistry, Genetics and Molecular Biology52.2%
  • Medicine39.7%
  • Computer Science2.9%
  • Immunology and Microbiology2.4%
  • Engineering0.5%
  • Chemistry0.4%
  • その他1.9%

トピック

  • Breast Cancer Treatment Studies10.1%
  • Cancer Genomics and Diagnostics5.5%
  • HER2/EGFR in Cancer Research5%
  • Cancer Cells and Metastasis4.6%
  • Advanced Breast Cancer Therapies3.1%
  • Breast Lesions and Carcinomas2.8%
  • その他68.9%

共著者

全論文

検索で開く
  1. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 4,887

  2. Metastatic Behavior of Breast Cancer Subtypes

    著者: , , , , , , , - Journal of Clinical Oncology 2010 被引用: 2,284

  3. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

    著者: , , , , , , , , , , , , , , - Science Translational Medicine 2015 被引用: 1,132

  4. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

    著者: , , , , , , , , , , , , , , , , - JAMA 2006 被引用: 3,834

  5. Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A. Shaw, H. Tovey, A. Gutin, Vandna Shah, Andrew Tutt, A. Grigoriadis, Levi Fox, J.S. Lanchbury - Nature Medicine 2018 被引用: 903

  6. Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

    著者: , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2009 被引用: 2,220

  7. Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2020 被引用: 317

  8. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeroen van der Laak, Francesco Ciompi, Anne‐Vibeke Lænkholm, Enrique Bellolio, Tina Gruosso, Stephen B. Fox, Juan Carlos Araya, Giuseppe Floris, Jan Hudeček, Leonie Voorwerk, Andrew H. Beck, J. Kaplan Kerner, Denis Larsimont, Sabine Declercq, Gert Van den Eynden, Lajos Pusztai, Anna Ehinger, Wentao Yang, Khalid AbdulJabbar, Yinyin Yuan, Rajendra Singh, Crispin T. Hiley, Maise Al Bakir, Alexander J. Lazar, Stephen P. Naber, Stephan Wienert, Miluska Castillo, Giuseppe Curigliano, Maria Vittoria Dieci, Fabrice André, Charles Swanton, Jorge S. Reis‐Filho, Joseph A. Sparano, Eva Balslev, I‐Chun Chen, Elisabeth Ida Specht Stovgaard, Katherine L. Pogue–Geile, Kim Blenman, Frédérique Penault–Llorca, Stuart J. Schnitt, Sunil R. Lakhani, Anne Vincent‐Salomon, Federico Rojo, Jeremy Braybrooke, Matthew G. Hanna, María Teresa Soler-Monsó, Daniel Bethmann, Carlos Castaneda, Karen Willard‐Gallo, Ashish Sharma, Huang‐Chun Lien, Susan Fineberg, Jeppe Thagaard, Laura Comerma, Paula I. González-Ericsson, Edi Brogi, Sherene Loi, Joel Saltz, Frederick Klaushen, Lee Cooper, Mohamed Amgad, David Moore, Roberto Salgado, the International Immuno-Oncology Biomarker Working Group, Aini Hyytiäinen, Akira I. Hida, Alastair Thompson, Alexis Lefevre, Allen M. Gown, Amy Lo ほか 156 名 - npj Breast Cancer 2020 被引用: 206

  9. A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

    著者: , , , , , , , , , , , , , , - Clinical Cancer Research 2010 被引用: 824

  10. Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mairead MacKenzie, Maggie Wilcox, Cynthia Huang Bartlett, María Koehler, Mitch Dowsett, Judith M. Bliss, Samuel A. Jacobs - Journal of Clinical Oncology 2018 被引用: 235

  11. Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 590

  12. Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2004 被引用: 2,657

  13. Breast Cancer Subtypes and the Risk of Local and Regional Relapse

    著者: , , , , , - Journal of Clinical Oncology 2010 被引用: 1,242

  14. Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Oncologist 2015 被引用: 198

  15. Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natalia Lukashchuk, Michael O. Dorschner, Leylah Drusbosky, Ioannis Roxanis, Violeta Serra, Syed Haider, Stephen J. Pettitt, Christopher J. Lord, Andrew Tutt - Annals of Oncology 2024 被引用: 71

  16. Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William F. Anderson, Angela Cox, Simon S. Cross, Malcolm Reed, Elena Provenzano, Sarah‐Jane Dawson, Alison M. Dunning, Manjeet K. Humphreys, Douglas F. Easton, Montserrat García‐Closas, Carlos Caldas, Paul D.P. Pharoah, David G. Huntsman - PLoS Medicine 2010 被引用: 1,150

  17. Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Germán Corredor, Anders Bjorholm Dahl, Flávio Luis Dantas Portela, Frederik Deman, Sandra Demaria, Johan Doré Hansen, Sarah Dudgeon, Thomas Ebstrup, Mahmoud Elghazawy, Claudio Fernandez‐Martín, Stephen B. Fox, William M. Gallagher, Jennifer M. Giltnane, Sacha Gnjatic, Paula I. González-Ericsson, Anita Grigoriadis, Niels Halama, Matthew G Hanna, Aparna Harbhajanka, Steven N. Hart, Johan Hartman, Søren Hauberg, Stephen M. Hewitt, Akira I. Hida, Hugo M. Horlings, Zaheed Husain, Evangelos Hytopoulos, Sheeba Irshad, Emiel A. M. Janssen, Mohamed M. Kahila, Tatsuki R. Kataoka, Kosuke Kawaguchi, Kharidehal Durga, Andrey Khramtsov, Umay Kiraz, Pawan Kirtani, Liudmila L. Kodach, Konstanty Korski, Anikó Kovács, Anne‐Vibeke Lænkholm, Corinna Lang‐Schwarz, Denis Larsimont, Jochen K. Lennerz, Marvin Lerousseau, Xiaoxian Li, Amy Ly, Anant Madabhushi, Sai Maley, Vidya Manur Narasimhamurthy, Douglas K. Marks, Elizabeth S. McDonald, Ravi Mehrotra, Stefan Michiels, Fayyaz Minhas, Shachi Mittal, David A. Moore, Shamim Mushtaq, Nighat Hussain, Thomas Papathomas, Frédérique Penault‐Llorca, Rashindrie Perera, Christopher J. Pinard, Juan Carlos Pinto‐Cardenas, Giancarlo Pruneri, Lajos Pusztai, Arman Rahman, Nasir Rajpoot, Bernardo L. Rapoport, Tilman T. Rau, Jorge S. Reis‐Filho ほか 42 名 - The Journal of Pathology 2023 被引用: 52

  18. Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 被引用: 437

  19. Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sara M. Tolaney, Sarah H. Warren - Cancers 2021 被引用: 97

  20. Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandra Demaria, Sarah Dudgeon, Mahmoud Elghazawy, Scott Ely, Claudio Fernandez‐Martín, Susan Fineberg, Stephen B. Fox, William M. Gallagher, Jennifer M. Giltnane, Sacha Gnjatic, Paula I. González-Ericsson, Anita Grigoriadis, Niels Halama, Matthew G Hanna, Aparna Harbhajanka, Alexandros Hardas, Steven N. Hart, Johan Hartman, Stephen M. Hewitt, Akira I. Hida, Hugo M. Horlings, Zaheed Husain, Evangelos Hytopoulos, Sheeba Irshad, Emiel A. M. Janssen, Mohamed Kahila, Tatsuki R. Kataoka, Kosuke Kawaguchi, Kharidehal Durga, Andrey Khramtsov, Umay Kiraz, Pawan Kirtani, Liudmila L. Kodach, Konstanty Korski, Anikó Kovács, Anne‐Vibeke Lænkholm, Corinna Lang‐Schwarz, Denis Larsimont, Jochen K. Lennerz, Marvin Lerousseau, Xiaoxian Li, Amy Ly, Anant Madabhushi, Sai Maley, Vidya Manur Narasimhamurthy, Douglas K. Marks, Elizabeth S. McDonald, Ravi Mehrotra, Stefan Michiels, Fayyaz Minhas, Shachi Mittal, David Moore, Shamim Mushtaq, Nighat Hussain, Thomas Papathomas, Frédérique Penault‐Llorca, Rashindrie Perera, Christopher J. Pinard, Juan Carlos Pinto‐Cardenas, Giancarlo Pruneri, Lajos Pusztai, Arman Rahman, Nasir Rajpoot, Bernardo L. Rapoport, Tilman T. Rau, Jorge S. Reis‐Filho, Joana Ribeiro, David L. Rimm, Anne Vincent‐Salomon, Manuel Salto‐Tellez ほか 34 名 - The Journal of Pathology 2023 被引用: 49

  21. Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

    著者: , , , , , - The Oncologist 2013 被引用: 546

  22. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph T. Rabban, Yunni-Yi Chen, Dilip D. Giri, Alfred Au, Nola M. Hylton - Breast Cancer Research and Treatment 2011 被引用: 376

  23. Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

    著者: , , , , , , , - Clinical Cancer Research 2008 被引用: 1,188

  24. PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 被引用: 245